Search Results
Positive recommendations from DSMC for Leronlimab’s Phase 3 CD12 COVID-19 study & what this means
Biologic therapy for multidrug-resistant HIV offers new hope
CYDY stock CytoDyn analysis with Leronlimab
Panel Discussion with Dr. Pourhassan, Dr. Patterson, & Dr. Lalezari on treatment for COVID-19
2011 Scarsdale Distinguished Alumni Awards P8